slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
19.500 KRW | -8,24% |
|
-3,47% | +28,21% |
Vakgebied
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Manufacturing
99,7
%
| 107 307 | 99,8 % | 135 598 | 99,7 % | +26,36% |
Others
0,3
%
| 175 | 0,2 % | 355 | 0,3 % | +102,86% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
100,0
%
| 107 482 | 100,0 % | 135 953 | 100,0 % | +26,49% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jae-Hyeong Park
CEO | Chief Executive Officer | 58 | 16-10-20 |
Bok-Hwan Jeon
CEO | Chief Executive Officer | 60 | 16-10-20 |
Kang-Beom Kwon
AUD | Comptroller/Controller/Auditor | 54 | - |
So-Gyung Joo
PRN | Corporate Officer/Principal | 59 | 01-08-98 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tae-Hyeon Park
BRD | Director/Board Member | 66 | - |
Jae-Hyeong Park
CEO | Chief Executive Officer | 58 | 16-10-20 |
Bok-Hwan Jeon
CEO | Chief Executive Officer | 60 | 16-10-20 |
Man-Gyu Kim
BRD | Director/Board Member | 49 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 31 779 994 | 25 899 284 ( 81,50 %) | 581 ( 0,001828 %) | 81,50 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
1 118 192 | 1.41% | 6 840 551 $ | |
HLB INNOVATION CO.,LTD. 2.87% | 2 074 688 | 2.87% | 4 810 040 $ |
581 | 0.00% | 9 316 $ |
Bedrijfsgegevens
![Adres HLB Pharmaceutical Co., Ltd.(A047920)](https://cdn.zonebourse.com/static/address/64309610.png)
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+28,21% | 214 mln. | |
+54,88% | 815 mld. | |
+44,25% | 654 mld. | |
-6,49% | 354 mld. | |
+22,19% | 337 mld. | |
+10,45% | 302 mld. | |
+18,38% | 247 mld. | |
+2,09% | 229 mld. | |
+13,03% | 219 mld. | |
+9,47% | 171 mld. |
- Beurs
- Aandelen
- Koers A047920
- Onderneming HLB Pharmaceutical Co., Ltd.